Patients with endometrial cancer pose a very high risk of dying from cardiovascular diseases in the year after diagnosis, suggesting the necessity of early involvement of cardiologists for these patients.
Endometrial cancer survival correlates with total number of chemotherapy cycles – but not whether they are started earlier than radiation, according to the results of a new study.
A recent Danish study showed pregnancy loss was not associated with later cancer development among women with various cancer types.
COX7RP contributes to endometrial and breast cancer growth.
Diagnosis of endometrial carcinoma made easier by analysis of mutations in cervix or endometrial tissue.
Many clinical trials in breast and endometrial cancers are underway and recruiting patients.
The combination was simultaneously approved in Australia and Canada and was the first such action under a new international collaboration.
Researchers identified a highly recurrent, disease-specific PP2A PPP2R1A mutation as a driver of endometrial carcinoma and as a target for new drugs.
Researchers examined the results of ribociclib and letrozole as a treatment for patients with estrogen receptor-positive ovarian cancer and endometrial cancer.
A new study reinforces the need for universal mismatch repair protein immunohistochemistry screening of tumors from endometrial cancer patients, as well as germline genetic testing in accordance with guidelines.